A Phase 1 study of fianlimab in combination with cemiplimab in patients with anti–PD-1/L1-experienced cutaneous squamous cell carcinoma by J. Kaczmar, K. Papadopoulos, G. Ansstas, A. Birnbaum, J. Mehnert, O. Hamid, B. Hughes, G. Rabinowits, A. Wei, M. Yushak, J. Mani, F. Fang, J. Wang, G. Kroog, M. Salvati, I. Lowy, M. Fury, N.J. Lakhani

Get full text

Phase 2 study of intratumoral vidutolimod in combination with intravenous cemiplimab in patients with selected advanced cancer or metastatic cancer: trial in progress by S. Bhatia, D. Davar, S. Thomas, A.W. Silk, R.C. Wu, R. Ladwa, S.J. Park, C.M. Kelly, D.J. Wong, J. Grewal, N. Vohra, A.M. Lim, J. Puegero, C. Verschraegen, B. Zhong, I. Lowy, M. Fury, M. Cristea

Get full text